The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery

February 17, 2026 9:00 AM

WASHINGTON, DC, CHEVY CHASE, MD, and RESTON, VA / ACCESS Newswire / February 17, 2026 / The Naderi Center for Plastic Surgery & Dermatology is educating patients across the DMV on what to expect during recovery after earlobe repair surgery, a popular in-office procedure designed to correct torn, stretched, or elongated earlobes caused by heavy earrings, trauma, or aging. Performed In-Office with Local Anesthesia and Dissolvable SuturesEarlobe...

Read more

CVS Health Makes Health Insurance Simpler and More Affordable for Americans

February 17, 2026 9:00 AM

Originally published on CVS Health Company NewsCVS Health® recently announced key milestones in its ongoing effort to make health care simpler and more affordable for American consumers."Our ambition is to be America's most trusted health care company," said David Joyner, President and CEO of CVS Health. "We are partnering with the Administration and Congress to deliver common-sense solutions that make health care more affordable and improve...

Read more

Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion

February 17, 2026 9:00 AM

Alpha Genesis, Inc., America's largest primate research center, proudly announces the successful completion of its triennial re-licensing inspection by the United States Department of Agriculture under the Animal Welfare Act.The inspection, conducted by the USDA Animal and Plant Health Inspection Service, comes at a critical moment for AGI as the company expands capacity, increases breeding output, and scales research operations to meet rising...

Read more

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual powder formulation of Meclizine.The application, titled "A Sublingual Powder Formulation of Meclizine and Methods of Use Thereof,"...

Read more

African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens

February 17, 2026 8:25 AM

Against a backdrop of stalled progress, declining international funding, and intensifying threats, African Heads of State and Government today issued a unified call for a new era of malaria financing at the 39th African Union Summit in Ethiopia. The African Union Malaria Progress Report 2025, presented by President Advocate Duma Gideon Boko of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA) (www.ALMA2030.org),...

Read more

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

February 17, 2026 8:25 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the Company's recently appointed President and Chief Executive officer, Rami Levin, in close alignment with the Board of Directors, has recruited key members to his new executive team. These new appointments,...

Read more

Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models

February 17, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing small-molecule therapeutics targeting fundamental epigenetic and metabolic drivers of cancer, today announced new in vitro data demonstrating that Telomir-1 (Telomir-Zn) induces broad tumor cell mortality across biologically distinct subtypes of triple-negative breast cancer (TNBC).Iron-rescue experiments confirmed that...

Read more

Black Book's 2026 State of Behavioral Health IT Report Ranks Netsmart #1

February 17, 2026 7:45 AM

Black Book Market Research released its 2026 State of Behavioral Health IT report, a comprehensive market benchmark spanning over twenty behavioral health IT categories and scored using Black Book's 18‑KPI performance framework.The report's 2026 Behavioral Health IT User Survey (n=1,104) captures the lived experience of frontline clinicians, prescribers, revenue cycle leaders, IT analysts, and executive decision-makers across outpatient,...

Read more

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

February 17, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older.This marketing authorization follows the positive opinion adopted by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) and marks Moderna's...

Read more

AGFA HealthCare Brings KLAS-Awarded Enterprise Imaging That Reduces Complexity to HIMSS 2026

February 17, 2026 3:45 AM

At HIMSS 2026, AGFA HealthCare will showcase its latest Enterprise Imaging innovations designed to simplify IT operations, strengthen interoperability, and deliver a faster, more intuitive imaging experience for clinicians. Building on three consecutive years of Best in KLAS® recognitions, attendees can visit Booth #2225 to explore how AGFA HealthCare is helping organizations bring clarity back to imaging complexity.As healthcare systems...

Read more

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

February 17, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the European Patent Office (EPO) has issued a Decision to Grant European Patent No. 4539857 covering the Company's proprietary sublingual cladribine oral thin film (ODF) drug delivery technology.The grant will take effect upon publication of the mention of grant in...

Read more

Vanna Health Appoints Liz Kwo, MD, MBA, MPH as President to Lead Next Phase of National Growth

February 16, 2026 4:15 PM

Vanna Health, a leader in value-based care for people with serious mental illness (SMI), today announced that Dr. Liz Kwo has joined the company as President. In this role, Dr. Kwo will partner closely with Founder and CEO Dr. Giovanni Colella to guide Vanna Health through its next phase of growth, including multi-state expansion, deeper payer partnerships, and continued scaling of its community-based care model and technology platform.Vanna...

Read more

Why Keloids Keep Growing According to Dr. Mendez and Dr. Salloum

February 16, 2026 9:00 AM

Keloid scars affect millions of people worldwide, yet many patients remain confused about why these scars continue to grow long after a wound has healed. According to specialists at The Keloid Plastic Surgery Center in Miami, keloids are not simply cosmetic scars-they are the result of an overactive healing response that can progress unpredictably without appropriate treatment.Led by Dr. Roberto Mendez and Dr. Gabriel Salloum, the center focuses...

Read more

Save a Life by NHCPS Transitions to Advanced Medical Certification to Unify Accredited Online Training

February 16, 2026 8:00 AM

Save a Life by NHCPS, a global initiative dedicated to empowering individuals through free life support education, is officially merging with its parent company Advanced Medical Certification (AMC) to unify its accredited training programs under one trusted platform. The transition marks the next phase in Save a Life's mission to make high-quality, accessible medical education available to everyone - while offering a more streamlined and...

Read more

Leafbuyer Technologies Reports Second Quarter Fiscal 2026 Results

February 16, 2026 8:00 AM

Leafbuyer Technologies, Inc. (OTC:LBUY), a leading cannabis marketing technology platform, today announced financial results for the quarter ended December 31, 2025, as reported in its Form 10-Q filed with the Securities and Exchange Commission.For the three months ended December 31, 2025, revenue totaled approximately $962,802, compared to $1,717,127 in the same period last year, reflecting a 43% year-over-year decrease. Gross profit for the...

Read more

Sartorius Sharpens Climate Targets and Receives Validation from Science Based Targets Initiative

February 16, 2026 5:15 AM

The life science group Sartorius has sharpened its medium-term climate targets and received validation from the Science Based Targets initiative (SBTi). The organization confirmed that the new greenhouse gas reduction targets are in line with the Paris Climate Agreement."We have refined our climate targets and, with SBTi validation, taken an important step that is increasingly expected in our industry: science-based targets aligned with the...

Read more

iZafe Group's Quarterly Report Q4, October-December 2025

February 16, 2026 3:00 AM

iZafe Group AB (publ.)(STO:IZAFE-B) today, February 16, publishes its report for the fourth quarter.Financial Performance in SummaryThe Group's total net sales for the quarter amounted to 2,435 TSEK (2,345) and consisted entirely of recurring license revenues, with no hardware sales during the period. This is in contrast to the corresponding quarter of the previous year, when revenues were largely derived from hardware sales. The development...

Read more

ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results

February 13, 2026 5:05 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its third fiscal quarter ended December 31, 2025 of Fiscal Year 2026.The upward trend in revenues, as reported in the Company's previous quarterly reports, continues for this third fiscal quarter of fiscal year ended March 31, 2026. For the nine months ended December 31, 2025 revenues increased 9%...

Read more

National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney

February 13, 2026 2:00 PM

DaVitaWhen Holly's husband, Heston, was diagnosed with end-stage kidney disease, their lives changed overnight - bringing months of uncertainty. Driven to make a meaningful impact, Holly left her job to become a patient care technician at DaVita, turning her lived experience into guidance and support for others on their kidney journey.Last year, Holly made the selfless decision to donate her kidney. While she wasn't a match to donate to Heston,...

Read more

Turning Capes Into Care

February 13, 2026 1:50 PM

The Super Jake Foundation will host its annual Red Cape Gala on Saturday, February 14, 2026, at 6:00 p.m. at the Marriott Lincolnshire, bringing together supporters, families, and community leaders for an evening dedicated to hope, healing, and heroic impact.Created in memory of Jake Robert Widman, a young boy who battled neuroblastoma with the heart of a superhero, the Super Jake Foundation is committed to funding research for a cure and...

Read more